Shares of Senseonics Holdings, Inc. (NASDAQ:SENS) rose 3.8% during trading on Wednesday . The stock traded as high as $1.09 and last traded at $1.09, approximately 22,318 shares were traded during mid-day trading. A decline of 99% from the average daily volume of 1,828,276 shares. The stock had previously closed at $1.05.

The company has a fifty day moving average of $1.32 and a 200 day moving average of $2.07.

About Senseonics (NASDAQ:SENS)

Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.

See Also: Outstanding Shares, Buying and Selling Stocks

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.